Alcon
Alcon manufactures intraocular lenses, which replace the natural lens removed during cataract surgery. It is the second largest division of Swiss group Novartis.
Alcon operates in more than 75 countries, serving 180 markets and employing more than 24,000 people. The Cork centre manufactures AcrySof® intraocular lenses, the most frequently implanted lenses worldwide.
Technologies and processes featured at the Cork site include mould-tool manufacturing, monomer formulation, casting, curing/polymerization, high precision optical measurement and packaging. Approximately 400 employees work at the site.
Financial Data
-
31st Dec 18 Source: CRO
- €58.7 million turnover
-
€2.3 million
profit - 413 employees
-
31st Dec 17 Source: CRO
- €46.4 million turnover
-
€1.5 million
profit - 404 employees
- 5 more years available »
Ranking
By Turnover
(€58.7 million)- 653rd in Top Companies
- 65th in Pharma
By Employees
(413)- 410th in Top Companies
- 38th in Pharma
- 413
- €58.7 million
Employees
- Jackie Murphy Country Manager
Latest News
- Jul 14 Aviva brings case over €5.5m sale of Bank of Ireland building
- Jul 14 Republic risks becoming ‘Europe’s North Korea’ on air travel, says Aercap chief
- Jul 14 State to provide grant aid to commercial bus operators
- Jul 14 INM acquires motor data company Cartell.ie
- Jul 14 Inflazome secures orphan drug status for Inzolemid